David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 1,413 shares at $16.56 ($23K) on 2018-03-07, disclosed to the SEC on 2018-03-09.
Seasonal sale ($23k) by Chief Accounting Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |